Purpose: To study clinical profile, neurodevelopmental outcome and its predictors in children with acute symptomatic seizures (ASS). Methods: Short-term neurodevelopmental outcome and predictors of poor outcomes were prospectively assessed in 105 consecutive children with ASS aged 3 months-12 years Results: Mean age was 51.2 + 42.2 months (3-144 months); 67.2% were males. Central nervous system (CNS) infection in 82%, status epilepticus in 15.2%, abnormal neuroimaging in 62.8% and abnormal electroencephalography in 22.3% were noted. At discharge, 27.6% had poor outcome including death (13%); CNS infections were significantly associated with poor outcome compared to ASS of other aetiologies (32.6% vs 5.2%, p = 0.02). Low GCS (OR 4.9, 95%CI 1.2-20.7), abnormal electroencephalograph (OR 4.3, 95%CI 1-16.9) and neuroimaging (OR 12.1, 95%CI 1.4-105.2) were independent predictors of poor outcome. After 6 months, 16% children had delayed neurodevelopment and cognition; 6% had seizure recurrences. Abnormal electroencephalograph (p = 0.002; OR 6.8, 95%CI 2.0-23.1), abnormal neuroimaging (p = 0.015; OR 9.47, 95%CI 1.18-75.8), > 1 anti-epileptic (p = 0.00; OR 9.9, 95%CI 2.88-33.9), intubation (p = 0.004; OR 6.25, 95%CI 1.79-21.7) and poor outcome at discharge (p = 0.02; OR 4.44, 95%CI1.38-14.2) predicted abnormal neurodevelopment. Conclusions: CNS infections are the most common cause of ASS in children from developing countries. Abnormal neurodevelopment and seizure recurrences on short-term follow-up are seen in a minority of children.
Introduction
An acute symptomatic seizure is defined as a clinical seizure occurring in close temporal relationship with an acute central nervous system (CNS) insult, which may be metabolic, toxic, structural, infectious, or inflammatory [1] . Overall acute symptomatic seizures represent nearly 40% of total seizures [2] , 40% of all cases of afebrile seizures [3] and 50-70% of status epilepticus episodes [4] . The overall life-time risk of developing an acute symptomatic seizure is 3.6% which approaches that of developing epilepsy [2, 3] . The prevalence of acute symptomatic seizures among medical admissions varies from 2 to 5% in developing countries and is reported to be 3.5% among medical intensive care unit patients in the USA [5] [6] [7] .
The etiological spectrum of acute symptomatic seizures in developing countries is distinctly different from that of developed countries where cerebrovascular disease and traumatic brain injury are reported as the major aetiology in the adult population [2, 8] and acute gastroenteritis in children [9] . On the other hand, CNS infections are reportedly the most common cause of acute symptomatic seizures in developing countries in adults [5, 6] . The final outcome of acute symptomatic seizures depends upon the underlying aetiology [10] . Robust clinical data on the prognosis of acute symptomatic seizures in children is lacking and the available studies are largely retrospective in nature [11, 12] .
Acute symptomatic seizures have been identified as a major risk factor for neurological and cognitive impairment as well as development of epilepsy in children from developing countries [13] . In a study of 900 children with acute seizures admitted to a rural Kenyan district hospital, 3.1% patients died in the hospital while 1.3% had major neurological deficits on discharge [14] . Nearly 14% of children who survive acute symptomatic seizures develop subsequent unprovoked seizures by 5 years of age [15] . Nearly one-third of children admitted for status epilepticus have been shown to develop behavioural, emotional problems and other neurodevelopmental problems 7 years after discharge from the hospital [16] . Even in adults, the risk of 1-month mortality has been shown to be 8.9 times higher in individuals with first acute symptomatic seizure as compared to individuals with first unprovoked seizure although the risk of 10-year mortality is same and the risk of a subsequent unprovoked seizure is 80% less likely [11] . Evidently, there is paucity of studies on the clinical profile and neurodevelopmental outcomes of acute symptomatic seizures in children from developing countries. Hence, the current study was planned to (1) describe the clinical and etiological profile of acute symptomatic seizures in children (2) to describe the neurodevelopmental outcomes and (3) to identify predictors of poor outcomes in these children presenting to the paediatric emergency. Early prediction of neurological outcome may help in planning the frequency and duration of follow-up and long-term antiepileptic drug (AED) use.
Methodology

Methods
The study was conducted for a period of 1-year at the Post Graduate Institute of Medical Education and Research, Chandigarh, India which is a premier tertiary care centre of Northern India. A written, informed consent from the parents and assent from the child wherever applicable, was obtained.
Inclusion criteria
All consecutive children presenting to the paediatric emergency in the Department of Paediatrics with seizure were screened. Of these, children aged 3 months to 12 years with normal pre-morbid development and first acute symptomatic seizures were enrolled.
Exclusion criteria
Children with pre-existing developmental delay (based on history given by parents in the emergency room), febrile seizure, seizure disorder, systemic illness and non-convulsive status epilepticus were excluded. As children with pre-existing developmental delay and seizure disorder are commonly associated with epilepsy or have an underlying predisposition to unprovoked seizures as well as neurodevelopmental comorbidities such as learning difficulties and intellectual disabilities, hence they were excluded from the study.
Definitions
Acute symptomatic seizure was defined as a clinical seizure occurring in close temporal relationship with an acute CNS insult, which may be metabolic, toxic, structural, infectious, or inflammatory [1] . Seizure recurrence was defined as any seizure after 24 h of the first seizure [1] . Status epilepticus was defined as an epileptic seizure of >30 min duration or intermittent seizures without an intervening period of recovery of consciousness of >30 min duration [1] . Any child who continued to convulse when brought to the paediatric emergency was considered to be in status epilepticus (SE).
Measures
Seizures in the presence of active CNS infection such as meningitis, meningoencephalitis, neurotuberculosis, neurocysticercosis or brain abscess were grouped into 'acute symptomatic seizures due to CNS infections'. Diagnosis of meningitis was considered based on clinical features such as presence of seizures with or without impaired consciousness and/or signs of meningeal irritation in a febrile child and suggestive cerebrospinal fluid (CSF) features including polymorphonuclear cell count !20/mm [3] , protein >40 mg%, CSF glucose <40 mg% or a CSF:blood glucose ratio <0.2 in the presence of positive gram stain or culture from CSF and/ or a positive blood culture [17, 18] . Diagnosis of meningoencephalitis was based on clinical features such as fever and altered sensorium in addition to CSF lymphocytic pleocytosis, elevated protein level, neuroimaging evidence of cortical involvement, and/ or identification of an organism with enzyme linked immunosorbent assay or polymerase chain reaction (PCR) for common viral illnesses in our setting such as herpes simplex, enterovirus or Japanese encephalitis virus.
Clinical and etiological profile was compared between infants (3 months to 1 year) and children (1 year to 12 years). Socioeconomic status of family was classified according to Kuppuswamy Scale [19] . This scale has 3 components: family education, occupation and family income per month. Each component has 7 sub-components and socioeconomic status has been defined according to the total of each component score and a total score of 10 is defined as low socioeconomic status. All relevant investigations such as serum biochemistry, metabolic and toxic screen, neuroimaging and lumbar puncture were done to establish aetiology according to the standard unit protocol. Electroencephalography (EEG) was done in all patients at admission. Acute seizures were managed according to the standard unit protocol [20] . Treatment details including number of AEDS used for controlling seizure, neuroimaging features and EEG characteristics were noted on a pre-structured proforma. Children who had recurrent seizures, status epilepticus (SE), and persistent abnormal neurological examination at discharge and/or who had a structural lesion on neuroimaging were discharged on AED prophylaxis.
Outcome
Outcome was defined as good if the patient was discharged with minor or no sequelae and as poor when the patient died or was discharged with major sequelae (vegetative state, motor deficits, language deficits, behavioural problems disrupting daily activities, vision or hearing impairment etc). Follow-up of all patients was done at 3 and 6 months after discharge. Seizure recurrences and neurological examination details were noted. Developmental profile-3 (DP3) was used to assess neurodevelopment overall as well as in the individual domains of physical, adaptive, social development, cognition and communication [21] . Each of these domains has 34 to 38 test items. Scores in each of the five individual sector were calculated and a general development score (GDS) was derived. GDS value <70 was used as cut-off for 'delayed development'. Cognitive profile was used as surrogate marker of intelligent quotient. Scores <70 were considered as delay, whereas scores between 70 and 84 as below average, scores between 85 and 115 as average and scores between 116 and 130 were considered as above average. DP3 is a developmental screening tool designed to assess the development and functioning of children from birth through age 12. It is designed to interview the child's parent or caregiver and additionally offers a parent/ caregiver checklist version which consists of same item content as the interview form and can be given to a parent and caregiver to complete alone and, then scored later by the clinician. EEG and brain-stem evoked response audiometry (BERA) were done in all the patients.
Statistical analysis
Categorical variables were compared using student's t-test, chisquare test (for parametric data) and Mann-Whitney U test (for non-parametric data). Univariate analysis was used to identify the predictors of poor outcome and variables associated with poor outcome were further analysed by multivariate logistic regression analysis to obtain independent predictors of poor outcome. Level of significance was considered as p value <0.05. The study was approved by the institutional ethics committee.
Results
A total of 604 children presented with seizures in the paediatric emergency over a period of 4 months. Of these, 42 patients were <3 months of age and another 231 had unprovoked seizures, hence were excluded from the study. Of the remaining 331 children with provoked seizures, 226 children were excluded due to the presence of pre-existing developmental delay, febrile seizures, underlying chronic systemic illness or refusal for consent. Hence, based on the inclusion criteria selected for the study, a total of 105 children (71 boys, 34 girls) who presented with new-onset acute symptomatic seizures could be enrolled. The clinical profile, aetiology and outcome at discharge are presented in Table 1 . The two etiological groups were compared and clinical variables acute symptomatic seizures associated with individual aetiology were studied (Table 2) . Similar comparisons were also done for children with and without SE (Table 3 ).
Follow up
Of the 105 children, 14 children died during the acute illness and 6 were lost to follow-up. Hence 85 children were followed up 3 and 6 months after discharge.
At 3 months after discharge from the hospital, 15 (17.6%) were neurologically abnormal, 4 (4.7%) had abnormal EEG, 4 (4.7%) had abnormal neuroimaging and 1child (1.
At 6 months post-discharge, 11 children out of these 15 children continued to be abnormal while 4 improved and became normal.
Neurodevelopmental assessment with DP3 at 6 months showed that 14 (16.4%) children had delayed general developmental scores, 14 (16.4%) were below average, 54 (63.5%) were average and 3 (3.5%) patients were above average. On the cognitive subscale, 14 (16.4%) children had delayed score while 21 (24.7%) were below average, 46 (54.1%) were average and 4 (4.7%) patients were above average. Specifically, of the 15 children who were neurologically abnormal on clinical examination, 14 had below average and 1 had average general developmental score.
Seizure recurrence was noted in 5.8% (n = 5/85) children, all had been diagnosed with CNS infections. EEG was abnormal in 4 of these children: right temporal and left fronto-parietal focal epileptiform discharges and diffuse slowing were noted in one each (all three had meningoencephalitis) and multifocal epileptic discharges in the fourth patient who was an infant with multiple brain abscesses. BERA was normal in all patients at 6 months follow-up. (Table 4) . Multiple logistic regression analysis showed that low GCS (GCS 8) at admission (OR 4.9, 95% CI 1.2-20.7), abnormal neuroimaging (OR 12.1, 95% CI 1.4-105.2) and abnormal EEG (OR 4.3, 95% CI 1-16.9) were independent predictors of poor outcome.
Discussion
Etiology of acute symptomatic seizures
CNS infections emerged to be the dominant cause (82% overall) of acute symptomatic seizures in both infants (66.6%) and older children (88.9%) in our study. Meningitis and meningoencephalitis were most common (48.5% and 52.8% respectively) followed by neurotuberculosis (15% and 18% respectively) in these age groups. The causes of acute symptomatic seizures in children from developing countries differ from developed countries where acute gastroenteritis followed by encephalitis/encephalopathy, bacterial CNS infections and intracranial hemorrhages predominate [9, 15] . Even in adults, traumatic brain injury, stroke and metabolic insults dominate over acute CNS infections in developed countries [2, 22] whereas infections supersede stroke and metabolic-toxic insults in developing countries [6] .A high frequency of acute seizures in children related to infections such as neonatal infections, cerebral malaria, meningitis and viral encephalitis have been reported [17] . Clearly, the burden of CNS infections is huge in these resourceconstrained areas and governs the etiological spectrum of several acute neurological conditions in children including acute symptomatic seizures [5] . Although the risk of acute symptomatic seizures occurring in patients with acute CNS infections is more with encephalitis than meningitis [23] , we could not study these categories separately. Viral pathogens (herpes simplex, Japanese encephalitis, and enterovirus) were isolated by polymerase chain reaction in nearly 1/3rdcases of suspected cases of acute meningoencephalitis. However due to resource-constraints, a detailed molecular testing for all viruses and atypical organisms could not be carried out. Although many studies include neonatal seizures, we excluded infants below 3 months of age because the causes and susceptibility to seizures are quite different in this age group and make the results heterogeneous [2, 18] . Nevertheless, as there is dearth of information on the etiology, clinical presentation and outcome of pediatric acute symptomatic seizures, our study provides relevant data on the subject from India.
Type of seizures
Nearly two-thirds of children in our study had generalized seizures; the rest one third had either focal or focal with secondary generalisation. This is comparable to the results from available studies in children and adults where generalized seizures occur in 55-59% of patients and focal (with or without secondary generalisation) seizures are seen in a minor group (7-8%) [5, 9] . In our study, status epilepticus was noted in 12% of infants and 16.6% of older children. All the children with status epilepticus had underlying CNS infection. Raised intracranial pressure, requirement of intubation and abnormal electroencephalograph were significantly more in children with status epilepticus than in those without it portending a poorer outcome. Status epilepticus is known to cause cerebral oedema and raised intracranial pressure secondary to a variety of biochemical and metabolic consequences [24] . Acute symptomatic status epilepticus has been noted in 29-54% of patients, including both children and adults being admitted to the intensive care. CNS infections are the provoking risk factor in 28-67% of adult cases in developing countries as compared to 4-19% in developed countries. The figures are higher in children and confirm the higher burden of CNS infections in acute care neurology. Our findings also provide further support to the fact that CNS infections are the most common cause of status epilepticus in children, especially in developing countries. The presence of status epilepticus adversely affects the discharge outcome of children with acute symptomatic seizures.
Discharge outcome
In our study, 13.3% children died during the acute illness, all of whom had underlying CNS infection. Of these,10 children had abnormal neuroimaging suggesting that structural pathology may govern the mortality. As is well-known, mortality after the first seizure is increased in the youngest patients and in those with symptomatic seizures [22] . However, among survivors of acute symptomatic seizures, only those who had an underlying CNS infection experienced deaths in the 10-year period (13.6%, 95% CI 6.6-27.1%) [11] . thus seizure etiology remains the single most important risk factor for increased mortality in patients with a first seizure [22] . Population-based studies support the fact that the short-term mortality is fairly high after an acute symptomatic seizure and a first episode of status epilepticus, both in children as well as adults [12, 22] . In a retrospective US population-based cohort study, the 30-day mortality of a first episode of status epilepticus was 19%. In a study of 900 children with acute seizures admitted to a rural Kenyan district hospital, the mortality rate was 3.1% [14] . The standardized mortality ratio may be as high as 10.3 (95% CI 8.3-12.7) and an acute symptomatic seizure is associated with a significantly higher risk of 30-day mortality (21.4% vs 3.4%, p < 0.001) compared to a first unprovoked seizure [11] . Additionally, in our study, 14.2% children were discharged with major sequelae all of whom remained neurologically abnormal at 3 months and three-fourth continued to be abnormal even at 6 months after discharge. The figures are higher than those reported from other developing countries such as Kenya (1.3%) [14] . Although the numbers are small, yet this reflects the burden of neurological illnesses due to a preventable cause such as CNS infection in children from developing countries. The predictors of poor outcome at discharge in our study were low socioeconomic class, status epilepticus low GCS at admission, requirement of intubation, presence of raised intracranial pressure, requirement of >1 AED to control seizures, abnormal neuroimaging and abnormal EEG during admission and underlying CNS infections. Abnormal EEG and neuroimaging and low GCS ( 8) were found to be independent predictors of poor outcome. Abnormal neuroimaging and progressive symptomatic seizures were predictive adverse outcomes in population-based studies in adults. Our study provides important clinical information in children regarding the predictors of outcome of acute symptomatic seizures which may help in planning early rehabilitation and long-term follow-up in these children.
Neurodevelopmental follow-up
In our study, the neurodevelopmental assessment at 6 months follow-up in children with acute symptomatic seizures showed delayed general developmental and cognitive scores in less than one-fifth of the patients (16.4%). Although majority of children developed normally after the acute event, the predictors of poor development in the affected children were poor seizure control requiring more than one AED, major sequelae at discharge, abnormal neuroimaging and abnormal EEG at admission. Acute symptomatic seizures have been identified as a major risk factor for neurological and cognitive impairment as well as development of epilepsy in children from developing countries [13, 14] . A recent study from Kenya looked at the neurocognitive outcome (by Ten Questions Questionnaire screen) and survival of children treated for convulsive status epilepticus 3 to 4 years after hospitaldischarge [16] . The study results showed death in 8%, neurological impairments in 30.9% and active epilepsy in 15% of survivors. Another study from Nepal highlighted the acute outcome of children admitted with seizures to the emergency room as death (4.4%), left against medical advice (4.4%), referral to another centre (1.8%) and successful treatment (89.4%). As majority of reported studies have either determined acute outcomes or have not used standardized neuropsychological tests to estimate the degree of cognitive impairments in the children, our study contributes important and relevant data from developing countries such as India.
Seizure recurrence and mortality in follow-up
No deaths were noted in our study in the follow-up period upto 6 months after discharge. Seizures recurred in 5.8% patients which is lower than other studies (14-15%) [5, 11] . Acute symptomatic seizures are an undisputable risk factor for subsequent epilepsy [22] . A first unprovoked seizure may be seen in upto one-third of children (28%) as early as six months after an acute symptomatic seizure [9] . By the age of 5 years, nearly 14% of survivors of acute symptomatic seizures have been reported to develop unprovoked seizures [15] . The risk of developing epilepsy has been noted to be higher for CNS infections (18-28%) confirming a higher burden of epilepsy in survivors of acute symptomatic seizures [15] . Additionally, the risk of an unprovoked seizure is significantly greater for children with acute symptomatic seizure and status epilepticus (100%) than without status epilepticus (22%), abnormal EEG (57% vs 9%) or neuroimaging (71% vs 11.5%) compared to those without an abnormality [9] . An epileptiform EEG has been shown to be the most important predictor of seizure recurrence following a first acute symptomatic seizure (p 0.005, odds ratio 16, 95% CI 4.08-62.7). Confirming to these observations, all children with seizure recurrence in our study had presented with status epilepticus and had abnormal EEG both during admission as well as in follow-up. Our data suggest that it may be worthwhile to do EEG at discharge and follow-up to identify children with risk of seizure recurrence and govern AED titration.
Study limitation and future research
The small sample size in our study limits the external validity of our results. Long-term neurodevelopmental outcomes in children with acute symptomatic seizures need to be studied as this may have implications for the burden of neurological illnesses secondary to CNS infections and their rehabilitation, especially in resource-limited settings.
Conclusion
Our study indicates that CNS infections are the dominant cause of acute symptomatic seizures and status epilepticus in children admitted to the emergency room in developing countries. Presence of status epilepticus adversely affects the discharge outcome of these children. Low socioeconomic class, presence of status epilepticus, raised intracranial pressure or low GCS at admission, requirement of intubation or >1 AED, abnormal neuroimaging and abnormal EEG during admission and underlying CNS infections predictor poor outcome at discharge. Overall developmental and cognitive scores are adversely affected at short-term and are predicted by poor seizure control, major sequelae at discharge, abnormal neuroimaging and abnormal EEG. Recurrent seizures are commonly seen in children with status epilepticus and abnormal EEG both during admission as well as in follow-up. Adverse effects of acute symptomatic seizures in the long-term need to be evaluated in studies involving larger number of children.
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